Skip to Content


Filter by:



Second Opinion

Learn about policy issues important to medical schools and teaching hospitals, with Executive Vice President Atul Grover, M.D., Ph.D.

Washington Highlights

White House Requests Supplemental Ebola Funding

November 7, 2014—The White House Nov. 5 submitted to Congress a request for $6.18 billion in emergency supplemental funding to contain the epidemic, strengthen domestic preparedness, and accelerate development of vaccines and treatments.

The president’s request includes $4.64 billion to respond to immediate needs domestically and globally, as well as $1.54 billion in a “Contingency Fund” that would be accessible as necessary “to ensure that there are resources available to meet unforeseen changes in the epidemic.”

Within the funding for immediate needs, the president requests $2.43 billion for the Department of Health and Human Services (HHS), the bulk ($1.83 billion) of which is directed to the Centers for Disease Control and Prevention (CDC) for investments in personal protective equipment (PPE), international efforts, and domestic preparedness at state and local health departments and “Ebola Treatment Centers.” The request also offers support to Ebola Treatment Centers and the Hospital Preparedness Program through the HHS Public Health and Social Services Emergency Fund.

Additionally, the HHS allocation supports research and related efforts through various agencies, including $238 million for the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) for advanced clinical trials of investigational vaccines and therapeutics, $25 million for the Food and Drug Administration (FDA), $157 million for the Biomedical Advanced Research and Development Agency (BARDA), and $10 million for modeling and genetic sequencing of the Ebola virus. Beside the HHS research investments, the White House requests $112 million for the Defense Advanced Research Projects Agency (DARPA) “to accelerate on-going research efforts focused on providing immediate, temporary immunity.”

Other immediate investments include support for offices within the State Department, including the U. S. Agency for International Development (USAID), which, in collaboration with CDC, has been the lead agency for the U.S. response to the epidemic in West Africa.

The $1.54 billion in contingency funding would be split between HHS ($751 million) and State ($792 million), with flexibility for the administration to transfer funding among federal agencies as needs arise both domestically and abroad.

Contact:

Tannaz Rasouli
Sr. Director, Public Policy & Strategic Outreach
Telephone: 202-828-0525
Email: trasouli@aamc.org

.

envelope on a green background

Subscribe to Washington Highlights

RSS icon

Subscribe to RSS

Washington Highlights, a weekly electronic newsletter, features brief updates on the latest legislative and regulatory activities affecting medical schools and teaching hospitals.


Past Issues


For More Information

Jason Kleinman
Sr. Legislative Analyst, Govt. Relations
Telephone: 202-903-0806
Email: jkleinman@aamc.org